Rheumatology NewsFRAX with BMD may not be accurate for women with diabetesAugust 22, 2019Osteoporosis
Rheumatology NewsSelf-reported falls can predict osteoporotic fracture riskAugust 19, 2019Osteoporosis
Rheumatology NewsAnalysis finds no mortality reductions with osteoporosis drugsAugust 19, 2019Osteoporosis
Rheumatology NewsBisphosphonates improve BMD in pediatric rheumatic diseaseAugust 14, 2019OsteoporosisPediatrics
Rheumatology NewsCathepsin Z identified as a potential biomarker for osteoporosisJuly 15, 2019Osteoporosis
Rheumatology NewsEldecalcitol may increase bone mineral density in poor responders to bisphosphonatesJuly 13, 2019Osteoporosis
Rheumatology NewsOsteoporosis, osteoarthritis risk high among cerebral palsy patientsJuly 11, 2019OsteoporosisOsteoarthritis
Rheumatology NewsOnce-weekly teriparatide still achieves bone mineral density gainsJuly 11, 2019Osteoporosis
Rheumatology NewsOsteoporotic fracture risk appears higher in adults with hemophiliaJuly 11, 2019Osteoporosis
Rheumatology NewsBisphosphonates before denosumab may prevent postdenosumab BMD rebound effectJune 20, 2019Osteoporosis
Rheumatology NewsConsider drug treatment in late-life women with osteoporosisJune 17, 2019Osteoporosis
Rheumatology NewsEmerging data support anabolic-first regimens for severe osteoporosisMay 14, 2019Osteoporosis
